Optibiotix Health

OptiBiotix Health PLC, formerly Ducat Ventures PLC, is a United Kingdom-based life sciences company developing compounds to tackle obesity, high cholesterol and diabetes. The Company develops a range of compounds which modify the human microbiome (the collective genome of the microbes in the body), to prevent and manage human disease. The Company has a pipeline of microbiome modulators that can impact on lipid and cholesterol management, energy harvest and appetite suppression. The product development pipeline is fuelled by its OptiScreen and OptiBiotic platform technologies designed to identify metabolic pathways and compounds. These platforms are applicable across a range of other human diseases.
Type
Public
HQ
Heslington, GB
Size (employees)
5 (est)
Optibiotix Health is headquartered in Heslington, GB

Optibiotix Health Office Locations

Optibiotix Health has an office in Heslington
Heslington, GB (HQ)
Innovation Way

Optibiotix Health Data and Metrics

Optibiotix Health Financial Metrics

Optibiotix Health's revenue was reported to be £28.2 k in FY, 2015
Numbers are in £, GBP

Revenue (FY, 2015)

28.2 k

Net income (FY, 2015)

(1.3 m)

EBIT (FY, 2015)

(1.4 m)

Market capitalization (26-May-2017)

58.6 m

Closing share price (26-May-2017)

0.8

Cash (30-Nov-2015)

2 m

EV

57.1 m
Optibiotix Health's current market capitalization is £58.6 m.
Numbers are in £, GBPFY, 2008FY, 2009FY, 2010FY, 2014FY, 2015

Revenue

28.2 k

Cost of goods sold

General and administrative expense

(489 k)(1.5 m)

Operating expense total

(489 k)(1.5 m)

EBIT

(489 k)(1.4 m)

EBIT margin, %

(5047%)

Interest income

9328

Pre tax profit

(30.2 k)(15.6 k)(37.3 k)(854 k)(1.4 m)

Income tax expense

43.3 k142.6 k

Net Income

(31.8 k)(15.6 k)(36.3 k)(810.7 k)(1.3 m)
Numbers are in £, GBPFY, 2008FY, 2009FY, 2010FY, 2014FY, 2015

Cash

870.9 k819.7 k779.3 k2.9 m2 m

Accounts Receivable

4.7 k62.6 k

Current Assets

875.6 k822.2 k782.9 k

PP&E

8552 k

Total Assets

5.2 m4.4 m

Accounts Payable

40.8 k3.8 k77.6 k125.8 k

Total Debt

529.5 k555.1 k

Additional Paid-in Capital

7.1 m7.1 m

Retained Earnings

(31.8 k)(15.6 k)(36.3 k)(7.8 m)(9 m)

Total Equity

4.6 m3.8 m

Shares Outstanding

885 k885 k885 k

Debt to Equity Ratio

0.1 x0.1 x

Debt to Assets Ratio

0.1 x0.1 x

Financial Leverage

1.1 x1.1 x
Numbers are in £, GBPFY, 2009FY, 2014FY, 2015

Cash From Operating Activities

(706.2 k)(1 m)

Purchases of PP&E

(1.1 k)(2 k)

Cash From Investing Activities

250.7 k(2 k)

Cash From Financing Activities

3.3 m155.9 k

Income Taxes Paid

(2 k)25.7 k43.3 k
Numbers are in £, GBPY, 2015

EV/EBIT

-40.1 x

EV/CFO

-55.6 x

Revenue/Employee

5.6 k

Debt/Equity

0.1 x

Debt/Assets

0.1 x

Financial Leverage

1.1 x

Optibiotix Health Operating Metrics

H1, 2016

Patents Issued

44

Patent Families

14

    Optibiotix Health Market Value History

    Optibiotix Health Online and Social Media Presence

    Optibiotix Health Company Life and Culture

    You may also be interested in